Results 251 to 260 of about 283,363 (298)
Some of the next articles are maybe not open access.

Atherosclerotic plaque development

The International Journal of Biochemistry & Cell Biology, 2009
Atherosclerosis is now recognized as an inflammatory/immunomodulatory reaction to the presence of oxidized low-density lipoproteins within the arterial wall, often times in the setting of such risk factors as family history, hypercholesterolemia, high blood pressure, diabetes mellitus and smoking.
Quang T, Bui   +2 more
openaire   +2 more sources

Devouring atherosclerotic plaques

Nature Nanotechnology, 2020
Targeting of local macrophages by functionalized carbon nanotubes enables efferocytosis and clearance of atherosclerotic plaques.
openaire   +2 more sources

Imaging of atherosclerotic plaque

The International Journal of Cardiovascular Imaging, 2004
The behavior and composition of coronary atherosclerotic plaques are ultimately responsible for the threat of acute ischemic events in patients with coronary artery disease. Different imaging modalities have been developed over the last several years in order to better characterize the atherosclerotic plaque and attempt to predict those in peril of ...
Mario A, Pulido   +2 more
openaire   +2 more sources

Development of atherosclerotic plaques

Acta Medica Scandinavica, 1985
ABSTRACT. Atherosclerosis is a multifactorial disease. A unified model for the lesion development reveals many connections between the response‐to‐injury hypothesis and the lipid hypothesis. Various cellular uptake mechanisms for native and modified lipoproteins are discussed with respect to foam cell formation and lesion development.
openaire   +2 more sources

Investigation of Atherosclerotic Plaque Vulnerability

2022
Histochemical and immunohistochemical approaches permit the detection and evaluation of proteins and cell types within murine brachiocephalic artery atherosclerotic plaques, that can be subsequently analyzed to provide inferences on atherosclerotic plaque vulnerability.
George, Sarah J, Johnson, Jason L
openaire   +3 more sources

MR imaging of atherosclerotic plaque

Radiologic Clinics of North America, 2002
MRI is a powerful noninvasive imaging tool with high spatial resolution that continues to prove its value in determining atherosclerotic plaque size, volume, and tissue components. Multispectral MRI sequences have been validated to characterize atherosclerotic plaque components in animals; they have recently been applied to human aorta and carotid ...
C Joon, Choi, Christopher M, Kramer
openaire   +2 more sources

Is regression of atherosclerotic plaque possible?

Clínica e Investigación en Arteriosclerosis (English Edition), 2017
As it is well-known, a thrombus evolving into a disrupted/eroded atherosclerotic plaque causes most acute coronary syndromes. Plaque stabilization via reduction of the lipid core and/or thickening of the fibrous cap is one of the possible mechanisms accounted for the clinical benefits displayed by different anti-atherosclerotic strategies.
José A, Páramo, Fernando, Civeira
openaire   +2 more sources

The Atherosclerotic Plaque

2009
Even though coronary, cerebral, and peripheral arterial disease represents the most common features of atherosclerosis, it progresses in the absence of any symptoms for most of its developmental course. Generally, the severity of a coronary stenosis is of poor predictive value for cardiac events such as sudden death, myocardial infarction, or unstable ...
Maddalena Piro   +2 more
openaire   +1 more source

Apoptosis in human atherosclerotic plaques

Apoptosis, 1999
Intimal cell death has been a recognized feature of advanced atherosclerotic disease. With the advent of DNA in situ end labelling and/or ultrastructural techniques, recent findings suggest that cells of an atheroma undergo programmed cell death or apoptosis. The pathophysiologic relevance of apoptosis in atherosclerotic disease is debatable. Apoptotic
F D, Kolodgie   +3 more
openaire   +2 more sources

Impact of Statins on Atherosclerotic Plaque

Future Cardiology, 2007
Lowering levels of low-density lipoprotein cholesterol with inhibitors of 3-hydroxy-methylglutaryl coenzyme A reductase (statins) has a profound impact on cardiovascular event rates. The degree of benefit is proportional to the extent of low-density lipoprotein cholesterol lowering achieved. In addition to lowering levels of atherogenic lipids, statins
Stephen J, Nicholls   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy